Article Details
Retrieved on: 2022-11-12 11:46:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... placebo-controlled long-term trial of anifrolumab—a human monoclonal antibody that targets the type I IFN receptor—in patients with lupus.
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here